Logo image of NTR.CA

NUTRIEN LTD (NTR.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:NTR - CA67077M1086 - Common Stock

81.75 CAD
-2 (-2.39%)
Last: 1/7/2026, 7:00:00 PM
Fundamental Rating

5

NTR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 27 industry peers in the Chemicals industry. While NTR belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. NTR may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

NTR had positive earnings in the past year.
NTR had a positive operating cash flow in the past year.
Each year in the past 5 years NTR has been profitable.
NTR had a positive operating cash flow in each of the past 5 years.
NTR.CA Yearly Net Income VS EBIT VS OCF VS FCFNTR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1.2 Ratios

NTR has a better Return On Assets (3.49%) than 85.19% of its industry peers.
NTR's Return On Equity of 7.20% is amongst the best of the industry. NTR outperforms 81.48% of its industry peers.
The Return On Invested Capital of NTR (4.86%) is better than 77.78% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NTR is in line with the industry average of 7.57%.
Industry RankSector Rank
ROA 3.49%
ROE 7.2%
ROIC 4.86%
ROA(3y)5.91%
ROA(5y)5%
ROE(3y)12.48%
ROE(5y)10.56%
ROIC(3y)8.34%
ROIC(5y)7.09%
NTR.CA Yearly ROA, ROE, ROICNTR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

NTR has a better Profit Margin (6.79%) than 92.59% of its industry peers.
NTR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 12.63%, NTR is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
In the last couple of years the Operating Margin of NTR has grown nicely.
Looking at the Gross Margin, with a value of 30.20%, NTR belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
NTR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.63%
PM (TTM) 6.79%
GM 30.2%
OM growth 3Y-13.46%
OM growth 5Y2.09%
PM growth 3Y-38.9%
PM growth 5Y-12.08%
GM growth 3Y-4.64%
GM growth 5Y1.41%
NTR.CA Yearly Profit, Operating, Gross MarginsNTR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NTR is destroying value.
Compared to 1 year ago, NTR has less shares outstanding
The number of shares outstanding for NTR has been reduced compared to 5 years ago.
NTR has a worse debt/assets ratio than last year.
NTR.CA Yearly Shares OutstandingNTR.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
NTR.CA Yearly Total Debt VS Total AssetsNTR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

NTR has an Altman-Z score of 1.79. This is a bad value and indicates that NTR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.79, NTR is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
NTR has a debt to FCF ratio of 6.46. This is a slightly negative value and a sign of low solvency as NTR would need 6.46 years to pay back of all of its debts.
NTR's Debt to FCF ratio of 6.46 is amongst the best of the industry. NTR outperforms 85.19% of its industry peers.
NTR has a Debt/Equity ratio of 0.53. This is a neutral value indicating NTR is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.53, NTR is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 6.46
Altman-Z 1.79
ROIC/WACC0.4
WACC12.09%
NTR.CA Yearly LT Debt VS Equity VS FCFNTR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

NTR has a Current Ratio of 1.41. This is a normal value and indicates that NTR is financially healthy and should not expect problems in meeting its short term obligations.
NTR's Current ratio of 1.41 is in line compared to the rest of the industry. NTR outperforms 44.44% of its industry peers.
A Quick Ratio of 0.89 indicates that NTR may have some problems paying its short term obligations.
The Quick ratio of NTR (0.89) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.89
NTR.CA Yearly Current Assets VS Current LiabilitesNTR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

NTR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.48%, which is quite good.
NTR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.65% yearly.
NTR shows a small growth in Revenue. In the last year, the Revenue has grown by 0.25%.
NTR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.28% yearly.
EPS 1Y (TTM)13.48%
EPS 3Y-17.44%
EPS 5Y10.65%
EPS Q2Q%148.72%
Revenue 1Y (TTM)0.25%
Revenue growth 3Y-2.14%
Revenue growth 5Y5.28%
Sales Q2Q%12.78%

3.2 Future

Based on estimates for the next years, NTR will show a small growth in Earnings Per Share. The EPS will grow by 2.73% on average per year.
Based on estimates for the next years, NTR will show a small growth in Revenue. The Revenue will grow by 1.62% on average per year.
EPS Next Y35.95%
EPS Next 2Y16.62%
EPS Next 3Y8.72%
EPS Next 5Y2.73%
Revenue Next Year2.75%
Revenue Next 2Y1.95%
Revenue Next 3Y1.14%
Revenue Next 5Y1.62%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NTR.CA Yearly Revenue VS EstimatesNTR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B
NTR.CA Yearly EPS VS EstimatesNTR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.65 indicates a correct valuation of NTR.
Based on the Price/Earnings ratio, NTR is valued cheaper than 88.89% of the companies in the same industry.
NTR is valuated rather cheaply when we compare the Price/Earnings ratio to 26.92, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 12.44, the valuation of NTR can be described as correct.
NTR's Price/Forward Earnings ratio is rather cheap when compared to the industry. NTR is cheaper than 85.19% of the companies in the same industry.
NTR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.65
Fwd PE 12.44
NTR.CA Price Earnings VS Forward Price EarningsNTR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NTR is valued cheaply inside the industry as 85.19% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NTR indicates a rather cheap valuation: NTR is cheaper than 81.48% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.04
EV/EBITDA 6.88
NTR.CA Per share dataNTR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NTR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.41
PEG (5Y)1.38
EPS Next 2Y16.62%
EPS Next 3Y8.72%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.67%, NTR has a reasonable but not impressive dividend return.
NTR's Dividend Yield is a higher than the industry average which is at 2.34.
Compared to an average S&P500 Dividend Yield of 1.94, NTR pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.67%

5.2 History

The dividend of NTR has a limited annual growth rate of 2.94%.
NTR has been paying a dividend for over 5 years, so it has already some track record.
As NTR did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)2.94%
Div Incr Years6
Div Non Decr Years6
NTR.CA Yearly Dividends per shareNTR.CA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

NTR pays out 58.76% of its income as dividend. This is a bit on the high side, but may be sustainable.
NTR's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP58.76%
EPS Next 2Y16.62%
EPS Next 3Y8.72%
NTR.CA Yearly Income VS Free CF VS DividendNTR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
NTR.CA Dividend Payout.NTR.CA Dividend Payout, showing the Payout Ratio.NTR.CA Dividend Payout.PayoutRetained Earnings

NUTRIEN LTD

TSX:NTR (1/7/2026, 7:00:00 PM)

81.75

-2 (-2.39%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-17 2026-02-17/amc
Inst Owners74.04%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap39.51B
Revenue(TTM)26.62B
Net Income(TTM)1.81B
Analysts72.59
Price Target68.21 (-16.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.67%
Yearly Dividend2.95
Dividend Growth(5Y)2.94%
DP58.76%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.24%
Min EPS beat(2)0.97%
Max EPS beat(2)9.5%
EPS beat(4)2
Avg EPS beat(4)-16.43%
Min EPS beat(4)-64.42%
Max EPS beat(4)9.5%
EPS beat(8)4
Avg EPS beat(8)-12.86%
EPS beat(12)4
Avg EPS beat(12)-17.39%
EPS beat(16)6
Avg EPS beat(16)-15.21%
Revenue beat(2)1
Avg Revenue beat(2)-1.03%
Min Revenue beat(2)-3.35%
Max Revenue beat(2)1.29%
Revenue beat(4)1
Avg Revenue beat(4)-3.6%
Min Revenue beat(4)-6.9%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-3.94%
Revenue beat(12)4
Avg Revenue beat(12)-3.47%
Revenue beat(16)5
Avg Revenue beat(16)-2.55%
PT rev (1m)1.56%
PT rev (3m)1.54%
EPS NQ rev (1m)-1.23%
EPS NQ rev (3m)14.63%
EPS NY rev (1m)-0.2%
EPS NY rev (3m)4.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.32%
Valuation
Industry RankSector Rank
PE 14.65
Fwd PE 12.44
P/S 1.07
P/FCF 13.04
P/OCF 6.89
P/B 1.14
P/tB 2.53
EV/EBITDA 6.88
EPS(TTM)5.58
EY6.83%
EPS(NY)6.57
Fwd EY8.04%
FCF(TTM)6.27
FCFY7.67%
OCF(TTM)11.87
OCFY14.51%
SpS76.07
BVpS71.76
TBVpS32.26
PEG (NY)0.41
PEG (5Y)1.38
Graham Number94.92
Profitability
Industry RankSector Rank
ROA 3.49%
ROE 7.2%
ROCE 8.09%
ROIC 4.86%
ROICexc 4.93%
ROICexgc 7.23%
OM 12.63%
PM (TTM) 6.79%
GM 30.2%
FCFM 8.24%
ROA(3y)5.91%
ROA(5y)5%
ROE(3y)12.48%
ROE(5y)10.56%
ROIC(3y)8.34%
ROIC(5y)7.09%
ROICexc(3y)8.53%
ROICexc(5y)7.25%
ROICexgc(3y)13.18%
ROICexgc(5y)11.36%
ROCE(3y)13.73%
ROCE(5y)11.62%
ROICexgc growth 3Y-18.22%
ROICexgc growth 5Y4.99%
ROICexc growth 3Y-16.71%
ROICexc growth 5Y6.12%
OM growth 3Y-13.46%
OM growth 5Y2.09%
PM growth 3Y-38.9%
PM growth 5Y-12.08%
GM growth 3Y-4.64%
GM growth 5Y1.41%
F-Score8
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 6.46
Debt/EBITDA 2.31
Cap/Depr 81.9%
Cap/Sales 7.36%
Interest Coverage 4.41
Cash Conversion 72.18%
Profit Quality 121.28%
Current Ratio 1.41
Quick Ratio 0.89
Altman-Z 1.79
F-Score8
WACC12.09%
ROIC/WACC0.4
Cap/Depr(3y)112.14%
Cap/Depr(5y)101.14%
Cap/Sales(3y)7.97%
Cap/Sales(5y)7.55%
Profit Quality(3y)156.44%
Profit Quality(5y)184.5%
High Growth Momentum
Growth
EPS 1Y (TTM)13.48%
EPS 3Y-17.44%
EPS 5Y10.65%
EPS Q2Q%148.72%
EPS Next Y35.95%
EPS Next 2Y16.62%
EPS Next 3Y8.72%
EPS Next 5Y2.73%
Revenue 1Y (TTM)0.25%
Revenue growth 3Y-2.14%
Revenue growth 5Y5.28%
Sales Q2Q%12.78%
Revenue Next Year2.75%
Revenue Next 2Y1.95%
Revenue Next 3Y1.14%
Revenue Next 5Y1.62%
EBIT growth 1Y19.73%
EBIT growth 3Y-15.31%
EBIT growth 5Y7.48%
EBIT Next Year100.07%
EBIT Next 3Y24.49%
EBIT Next 5Y13.49%
FCF growth 1Y-22.69%
FCF growth 3Y-13.08%
FCF growth 5Y-4.89%
OCF growth 1Y-26.52%
OCF growth 3Y-3.11%
OCF growth 5Y-0.72%

NUTRIEN LTD / NTR.CA FAQ

What is the ChartMill fundamental rating of NUTRIEN LTD (NTR.CA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NTR.CA.


Can you provide the valuation status for NUTRIEN LTD?

ChartMill assigns a valuation rating of 7 / 10 to NUTRIEN LTD (NTR.CA). This can be considered as Undervalued.


How profitable is NUTRIEN LTD (NTR.CA) stock?

NUTRIEN LTD (NTR.CA) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for NTR stock?

The Price/Earnings (PE) ratio for NUTRIEN LTD (NTR.CA) is 14.65 and the Price/Book (PB) ratio is 1.14.


What is the financial health of NUTRIEN LTD (NTR.CA) stock?

The financial health rating of NUTRIEN LTD (NTR.CA) is 4 / 10.